
Nubeqal 300mg. 120 tablets
Support your prostate health and treatment journey with Nubeqal 300mg (also known as Nubeqa), an advanced oral therapy designed for men with non-metastatic castration-resistant prostate cancer (nmCRPC).
The active ingredient, Darolutamide, is a next-generation androgen receptor inhibitor that effectively delays disease progression while maintaining a better safety and tolerability profile compared to traditional therapies.
Nubeqal is clinically proven to extend metastasis-free survival, helping patients maintain their quality of life and daily activities longer. Approved by the FDA, Nubeqal is trusted by oncologists worldwide as a key part of prostate cancer management.
$5,989.00
Ex Tax: $5,989.00
- Stock: In Stock
- Model: Tablets
- Weight: 150.00g
- SKU: 750131869272
- UPC: 750131869272